Edwards Lifesciences Corp (EW)vsMedtronic PLC (MDT)
EW
Edwards Lifesciences Corp
$82.50
+0.05%
HEALTHCARE · Cap: $48.94B
MDT
Medtronic PLC
$86.16
-0.82%
HEALTHCARE · Cap: $113.55B
Smart Verdict
WallStSmart Research — data-driven comparison
Medtronic PLC generates 485% more annual revenue ($35.48B vs $6.07B). EW leads profitability with a 17.7% profit margin vs 13.0%. MDT appears more attractively valued with a PEG of 1.55. MDT earns a higher WallStSmart Score of 56/100 (C).
EW
Buy53
out of 100
Grade: C-
MDT
Buy56
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-537.7%
Fair Value
$12.44
Current Price
$82.50
$70.06 premium
Margin of Safety
-254.0%
Fair Value
$24.34
Current Price
$86.16
$61.82 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 23.7%
Large-cap with strong market position
Reasonable price relative to book value
Strong operational efficiency at 20.0%
Generating 2.3B in free cash flow
Areas to Watch
Expensive relative to growth rate
Weak financial health signals
Premium valuation, high expectations priced in
Earnings declined 76.6%
Expensive relative to growth rate
Earnings declined 11.8%
Comparative Analysis Report
WallStSmart ResearchBull Case : EW
The strongest argument for EW centers on Operating Margin. Profitability is solid with margins at 17.7% and operating margin at 23.7%. Revenue growth of 13.3% demonstrates continued momentum.
Bull Case : MDT
The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin.
Bear Case : EW
The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 46.0x leaves little room for execution misses.
Bear Case : MDT
The primary concerns for MDT are PEG Ratio, EPS Growth.
Key Dynamics to Monitor
EW profiles as a mature stock while MDT is a value play — different risk/reward profiles.
EW carries more volatility with a beta of 0.93 — expect wider price swings.
EW is growing revenue faster at 13.3% — sustainability is the question.
MDT generates stronger free cash flow (2.3B), providing more financial flexibility.
Bottom Line
MDT scores higher overall (56/100 vs 53/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Edwards Lifesciences Corp
HEALTHCARE · MEDICAL DEVICES · USA
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Visit Website →Medtronic PLC
HEALTHCARE · MEDICAL DEVICES · USA
Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?